| |
Robert Schooley, MD
TROPICAL MEDICINE PUBLICATIONS
| 1 |
Zhang XQ, Fitzpatrick L, Campbell TB, Badaro R, Schechter M, Melo MD, Brites C, Pedral-Sampaio D and Schooley RT. Comparison of the prevalence of antibodies to human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) in Brazil and Colorado. J Infect Dis. 1998; 178:1488-91. |
| 2 |
Campbell TB, Borok M, Gwanzura L, MaWhinney S, White IE, Ndemera B, Gudza I, Fitzpatrick L and Schooley RT. Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. AIDS. 2000; 14:2109-16. |
| 3 |
Smith DM and Schooley RT. Running with Scissors: Using Antiretroviral Therapy without Monitoring Viral Load. Clin Infect Dis. 2008; 46: 1598-1600. |
| 4 |
Mehta SR, Huang R, Yang M, Zhang X-Q, Kolli B, Chang K-P, Hoffman RM, Goto Y, Badaro B and Schooley RT. Real time GFP imaging in a murine leishmaniasis model: a new tool for leishmania vaccine and drug discovery. Clin Vaccine Immunol. 12: 1764-70; 2008. |
| 5 |
Kumarasamy N, Madhavan V, Venkatesh KK, Saravanan S, Kantor R, Balakrishnan P, Devaleenol B, Poongulali S, Yepthomi T, Solomon S, Mayer K, Benson C and Schooley R. High frequency of clinically significant mutations following first-line generic HAART failure: Implications for second line options in resource-limited settings. Clin Infect Dis. 2009;49:306-9. |
| 6 |
Rodwell TC, Robertson A, Vera A, Anderson C; Lozada R, Aguirre N, Chait L, Schooley RT, Zhang, X-Q, Strathdee S. Rapid Response Survey of Influenza A (H1N1) in Marginalized Populations in Tijuana, Mexico: Lessons Learned. Emerging Infect Dis, 2010;16:1292-5. |
| 7 |
Holmes EC, Ghedin E, Halpin RA, Stockwell TB, Zhang, X-Q, Fleming R, Davey R, Benson CA, Mehta SR, Taplitz RA, Liu Y-T, Brouwer KC, Wentworth DE, Lin X, INSIGHT FLU002 Study Group and Schooley RT. Extensive Geographical Mixing of Human H1N1/09 Influenza A Virus in a Single University Community. J Virol, 2011; 14; 6923-9. |
| 8 |
Borok M, Fiorillo S, Gudza I, Putnam B,, Ndemera B, White IE, Gwanzura L, Schooley RT, Campbell TB. Evaluation of Plasma Human Herpesvirus 8 DNA as a Marker of Clinical Outcomes During Antiretroviral Therapy of AIDS-related Kaposi's Sarcoma in Zimbabwe. Clin Infect Dis. 2010;51:342-9. |
| 9 |
Lochhead MJ, Todorof K, Delaney M, Ives JT, Greef C, Moll K, Rowley K, Vogel K, Myatt C, Zhang XQ, Logan C, Benson C, Reed S, Schooley RT. Rapid multiplexed immunoassay for simultaneous serodiagnosis of HIV-1 and coinfections. J Clin Microbiol. 2011;49:3584-90. |
| 10 |
Lockman S, Hughes M, McIntyre J, Zheng Y, Chipato T, Conradie F, Sawe F, Asmelash A, Hosseinipour M, Mohapi L, Stringer E, Mngqibisa R, Siika A, Atwine D, Hakim J, Shaffer D, Kanyama C, Wools-Kaloustian K, Salata R, Hogg E, Alston-Smith B, Walawander A, Purcelle-Smith E, Eshleman S, Rooney J, Rahim S, Mellors J, Schooley R, Currier J. A Trial of Two Antiretroviral Therapies in Women with and without Prior Nevirapine Use. New Engl J Med, 363:1499-509. |
| 11 |
Mehta SR, Zhang X-Q, Badaro R, Spina C, Day J, Chang K-P and Schooley RT. Flow Cytometric Screening for Anti-Leishmanials in a Human Macrophage Cell Line. Experimental Parasitology, 2010; 126: 617-20. Orlov M, Vaida F, Finney OC, Smith DM, Talley AK, Wang R, Kappe SH, Deng Q, Schooley RT *, Duffy PE. P. falciparum Enhances HIV Replication in PBMCs Isolated from Humans Undergoing an Experimental Malaria Challenge PLoS One, 2012; 7: e39000. doi:10.1371 * corresponding author. |
| 12 |
Saravanan S, Madhavan V, Kantor R, Sivamalar S, Giomathi S, Solomon SS, Kumarasamy N, Smith DM, Schooley RT, Solomon S, Balakrishnan P. Unusual Insertion and Deletion at Codon 67 and 69 of HIV-1 Subtype C Reverse Transcriptase Among First-Line Highly Active Antiretroviral Treatment Failing South Indian Patients: Association with Other Resistance Mutations. AIDS Res Hum Retroviruses, 2012;28:1763-5. doi: 10.1089/AID.2011.0331. Epub 2012 May 21. |
| 13 |
Lockman S, Hughes M, Sawe F, Zheng Y, McIntyre J, Chipato T, Asmelash A, Rassool M, Kimaiyo S, Shaffer D, Hosseinipour M, Mohapi L, Ssali F, Chibowa M, Amod F, Halvas E, Hogg E, Alston-Smith B, Smith L, Schooley R, Mellors J, Currier J, the OCTANE (Optimal Combination Therapy After Nevirapine Exposure) ACTG A5208/OCTANE StudyTeam. Nevirapine- Versus Lopinavir/Ritonavir-Based Initial Therapy for HIV-1 Infection among Women in Africa: A Randomized Trial. PLoS Medicine, 2012; 9: e1001236. |
| 14 |
Noormahomed EV, Orlov M, do Rosario V, Petersen BW, Guthrie C, Badaro R, Schooley RT. A cross-sectional study of sub-clinical Plasmodium falciparum infection in HIV-1 infected and uninfected populations in Mozambique, South-Eastern Africa. Malar J. 2012;11:252. doi: 10.1186/1475-2875-11-252. |
| 15 |
Logan C, Givens M, Ives JT, Delaney M, Lochhead MJ, Schooley RT, Benson CA. Performance evaluation of the MBio Diagnostics point-of-care CD4 counter. J Immunol Methods. 2013;387:107-13. |
|
|
 |
|
